MNBTD
DNLI icon

Moody National Bank Trust Division’s Denali Therapeutics DNLI Stock Holding History

Moody National Bank Trust Division’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-218
Closed -$5K – 530
2019
Q1 		$5K Buy
+218
New +$4.56K ﹤0.01% 885

Other funds holding DNLI

CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Moody National Bank Trust Division's DNLI Position: Q2 2019 in Review

Moody National Bank Trust Division sold out of Denali Therapeutics (DNLI) in Q2 2019, closing a stake of 218 shares — an estimated $5K sold.

Moody National Bank Trust Division first reported a position in DNLI in Q1 2019 and held it in 1 quarter. The position peaked at $5K in Q1 2019. 114 funds tracked by Wall St. Rank hold DNLI as of Q2 2019.

  • Moody National Bank Trust Division reported no remaining Denali Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Moody National Bank Trust Division sold 218 Denali Therapeutics shares in Q2 2019, an estimated $5K.
  • Moody National Bank Trust Division first reported a position in Denali Therapeutics in Q1 2019 and held it in 1 quarter.
  • Moody National Bank Trust Division's Denali Therapeutics position peaked at $5K in Q1 2019.
  • 114 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2019.

Based on Moody National Bank Trust Division's 13F filing for Q2 2019, filed 22 Jul 2019.